Top 5 Emerging Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027
Summary
The Emerging 5 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
These countries contributed $288.2 billion to the global pharmaceuticals industry in 2022, with a compound annual growth rate (CAGR) of 9.1% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $451.7 billion in 2027, with a CAGR of 9.4% over the 2022-27 period.
Within the pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $213.2 billion in 2022. This was followed by Mexico and India with a value of $25.5 and $24.2 billion, respectively.
China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of $355.2 billion in 2027, followed by Mexico and India with expected values of $37.8 and $32.6 billion, respectively.
Scope
Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five pharmaceuticals market
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five pharmaceuticals market
Leading company profiles reveal details of key pharmaceuticals market players’ emerging five operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the emerging five pharmaceuticals market with five year forecasts
Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
Reasons to Buy
What was the size of the emerging five pharmaceuticals market by value in 2022?
What will be the size of the emerging five pharmaceuticals market in 2027?
What factors are affecting the strength of competition in the emerging five pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitors in the emerging five pharmaceuticals market?
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Top 5 Emerging Countries Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in South Africa
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in Brazil
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Pharmaceuticals in China
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Pharmaceuticals in India
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Pharmaceuticals in Mexico
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 Macroeconomic Indicators
12.1. Country data
13 Company Profiles
13.1. Aspen Pharmacare Holdings Ltd
13.2. Adcock Ingram Holdings Ltd
13.3. Novartis AG
13.4. Ache Laboratorios Farmaceuticos SA
13.5. EMS Sigma Pharma
13.6. Yangtze River Pharmaceutical Group
13.7. Shanghai Pharmaceuticals Holding Co Ltd
13.8. Yunnan Baiyao Group Co Ltd
13.9. Guangzhou Pharmaceutical Holdings Ltd
13.10. Sun Pharmaceutical Industries Ltd
13.11. Lupin Ltd
13.12. Dr. Reddy's Laboratories Limited
13.13. Aurobindo Pharma Ltd
13.14. Sanofi SA
13.15. Genomma Lab Internacional SAB de CV
13.16. Pfizer Inc.
14 Appendix
14.1. Methodology
14.2. About MarketLine
List of Tables
Table 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2018-27
Table 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2018-22
Table 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2022-27
Table 4: South Africa pharmaceuticals market value: $ billion, 2017-22
Table 5: South Africa pharmaceuticals market geography segmentation: $ billion, 2022
Table 6: South Africa pharmaceuticals market value forecast: $ billion, 2022–27
Table 7: South Africa size of population (million), 2018–22
Table 8: South Africa gdp (constant 2005 prices, $ billion), 2018–22
Table 9: South Africa gdp (current prices, $ billion), 2018–22
Table 10: South Africa inflation, 2018–22
Table 11: South Africa consumer price index (absolute), 2018–22
Table 12: South Africa exchange rate, 2018–22
Table 13: Brazil pharmaceuticals market value: $ billion, 2017-22
Table 14: Brazil pharmaceuticals market geography segmentation: $ billion, 2022
Table 15: Brazil pharmaceuticals market value forecast: $ billion, 2022–27
Table 16: Brazil size of population (million), 2018–22
Table 17: Brazil gdp (constant 2005 prices, $ billion), 2018–22
Table 18: Brazil gdp (current prices, $ billion), 2018–22
Table 19: Brazil inflation, 2018–22
Table 20: Brazil consumer price index (absolute), 2018–22
Table 21: Brazil exchange rate, 2018–22
Table 22: China pharmaceuticals market value: $ billion, 2017-22
Table 23: China pharmaceuticals market geography segmentation: $ billion, 2022
Table 24: China pharmaceuticals market value forecast: $ billion, 2022–27
Table 25: China size of population (million), 2018–22
Table 26: China gdp (constant 2005 prices, $ billion), 2018–22
Table 27: China gdp (current prices, $ billion), 2018–22
Table 28: China inflation, 2018–22
Table 29: China consumer price index (absolute), 2018–22
Table 30: China exchange rate, 2018–22
Table 31: India pharmaceuticals market value: $ billion, 2017-22
Table 32: India pharmaceuticals market geography segmentation: $ billion, 2022
Table 33: India pharmaceuticals market value forecast: $ billion, 2022–27
Table 34: India size of population (million), 2018–22
Table 35: India gdp (constant 2005 prices, $ billion), 2018–22
Table 36: India gdp (current prices, $ billion), 2018–22
Table 37: India inflation, 2018–22
Table 38: India consumer price index (absolute), 2018–22